INTRODUCTION This Manual Is a Safety Reference Do

Total Page:16

File Type:pdf, Size:1020Kb

INTRODUCTION This Manual Is a Safety Reference Do Laboratory Safety Manual – the University of North Carolina at Chapel Hill INTRODUCTION This manual is a safety reference document for laboratory personnel at the University of North Carolina at Chapel Hill. The University’s Department of Environment, Health & Safety prepared this manual, followed by review and approval from both the University’s Laboratory and Chemical Safety Committee (LCSC) and the University Safety and Security Committee (USSC). This manual provides basic information about hazards that you may encounter in the laboratory and safety precautions to prevent laboratory accidents and minimize exposure to hazardous chemicals. The Laboratory Safety Manual is part of the University's "Chemical Hygiene Plan" required by the U.S. Department of Labor’s Occupational Safety and Health Administration (OSHA) in its "Occupational Exposures to Hazardous Chemicals in Laboratories" Standard (29 CFR 1910.1450). Each laboratory that uses hazardous materials must have a copy of this manual readily accessible to employees in the laboratory. Each laboratory worker must be familiar with the contents that pertain to his or her workplace and the procedures for obtaining additional safety information needed to perform his or her duties safely. In order to keep the contents of this manual up-to-date with current regulations and best practices, EHS may periodically rewrite, add, or delete sections. You are not required to keep a printed copy of this manual unless your work location does not have access to an electronic version. Comments and suggestions for improving the manual are welcome and encouraged. Please send comments to: Director Environment, Health & Safety 1120 Estes Drive Extension, CB# 1650 (p) 919-962-5507 (f) 919-962-0227 email: [email protected] ______________________________________________________________________________ July 2014 LSM i Laboratory Safety Manual – the University of North Carolina at Chapel Hill EMERGENCY TELEPHONE NUMBERS (Post a copy of this page by your laboratory telephone.) PHONE HOURS Environment, Health and Safety 919-962-5507* 8:00 am- 5:00 pm (EHS) Work-Related Injuries 919-966-9119 8:30 am - 4:30 pm (normal work hours) Work-Related Injuries 919-966-7890 After hours (after hours) University Police 911 24 hours Fire or Smoke 911 24 hours Medical Emergencies 911 24 hours N.C. Poison Control Center 1-800-84 TOXIN 24 hours (1-800-848-6946) *University Police will contact EHS during non-business hours. SPECIAL INCIDENT REPORTING Gas Leaks or Odors: EHS – 919-962-5507 Chemical Spills: EHS – 919-962-5507 ______________________________________________________________________________ July 2014 LSM ii Laboratory Safety Manual – the University of North Carolina at Chapel Hill EHS - SCOPE OF SERVICE EHS employs a staff of professionals trained in the field of occupational and environmental health and safety to provide support for University activities and to assure a safe and healthful environment for employees, students and visitors. The Department’s sections include: Biological Safety The Biological Safety section provides general surveillance over activities involving biohazardous agents, monitors and reviews the performance and maintenance of containment systems, provides consulting services on aspects of biological safety, biosafety cabinets, and provides guidance and assistance concerning the packaging and shipping of biohazardous agents. Chemical Safety The Chemical Safety section works to anticipate, recognize, evaluate, and control personnel exposures to chemical hazards. The section provides consultative services to laboratory personnel on proper handling and storage of hazardous chemicals, laboratory chemical hoods, engineering controls, safety equipment and personal protective clothing. Environmental Affairs – Hazardous Waste Management The Environmental Affairs section has responsibility for oversight of environmental permitting and compliance activities, such as underground / above ground storage tank management, air quality permits (Title V), water quality (NPDES) permits, surface water quality, storm water management, wetland issues, and environmental assessments at inactive waste sites. This section also manages the hazardous and radioactive waste collection and disposal programs. Fire Safety and Emergency Response EHS’ Fire Safety and Emergency Response section is responsible for enforcing the North Carolina Building and Fire Codes, investigating fire incidents, developing evacuation procedures and maintaining fire alarm and extinguishing systems and coordinating the EHS Emergency Response and HazMat Team. Occupational and Environmental Hygiene The Occupational and Environmental Hygiene section is responsible for ensuring that indoor campus environments are conducive to good health and wellbeing, by recognizing, evaluating, and controlling health and safety hazards, using knowledge and experience in industrial hygiene, asbestos management, air and water quality, and safety engineering. The section assesses potential safety hazards, possible instances of exposure, and suitability of protective equipment. OEH works with facilities engineering and facilities services personnel to find ways to keep historical buildings functional, while protecting employee health, and works with planning, construction, and startup of new and renovated buildings to anticipate and eliminate building related health issues. Radiation Safety The Radiation Safety section provides services that include authorization for use of radioactive material and irradiators, personnel monitoring, x-ray safety surveys, sealed-source leak tests, and laboratory safety inspections. ______________________________________________________________________________ July 2014 LSM iii Laboratory Safety Manual – the University of North Carolina at Chapel Hill University Employee Occupational Health Clinic The University Employee Occupational Health Clinic (UEOHC) provides occupational health care services to all part-time, full-time, and temporary employee of the University of North Carolina at Chapel Hill. The UEOHC directs medical care for all workplace injuries/illnesses. The UEOHC also provides pre-employment screening, annual immunization reviews, and medical surveillance for healthcare and non-healthcare workers. Employees working in healthcare facilities are required to have annual immunization reviews. Other groups of employees are required to have medical surveillance screening if they work with asbestos, animals, or use respiratory protection, etc. Departments employing persons that require any services other than workplace incidents/injuries are charged for these services. Workplace Safety The Workplace Safety Section provides services to Industrial Maintenance and Construction, Support Services and Clinic Environments. We offer expertise in ergonomics, respiratory protection, safety training, medical surveillance, workers' compensation and safety management information system. OTHER RESOURCES EHS Website You can obtain additional information regarding EHS by accessing the EHS website. The website includes Health and Safety forms available for download, several self-study modules, access to employee training history, training schedules, annual reports, guidelines for recombinant DNA use, links to Safety Data Sheet sites, and much more. EHS continually updates the website to best serve the UNC community. Safety Training Safety training programs available to University personnel provide a review of safe practices and provide an orientation to University policies and state and federal regulations. The online New Employee Orientation for laboratory employees covers the following areas: laboratory safety (required for all laboratory personnel) use of fire extinguishers compliance with the OSHA standard for Occupational Exposure to Hazardous Chemicals in Laboratories, also known as the “OSHA Laboratory Standard” compressed gas cylinder safety biological safety hazardous waste Radiation safety training is also conducted by EHS. Contact EHS for a schedule of classes or to arrange a presentation for your laboratory. Animal handler training is available through the Office of Animal Care and Use. ______________________________________________________________________________ July 2014 LSM iv Laboratory Safety Manual – the University of North Carolina at Chapel Hill Condensed Laboratory Safety Information for New Research Personnel (Adapted from Responsible Conduct of Research 2005, Office of Vice Chancellor for Research & Economic Development) Safe use of hazardous materials requires knowledge of risks to the researcher, campus community, and environment. Researchers learn to handle hazardous materials safely during their scientific training and experience, as well as through information and training provided by their supervisors and the University’s Department of Environment, Health and Safety (EHS). This section summarizes some key requirements, and the subsequent chapters of this Laboratory Safety Manual expand on these requirements. Through campus committees, the University has established environment, health, and safety policies and procedures to minimize risk and comply with state and federal laws. These policies and procedures are in this Laboratory Safety Manual, the Radiation Manual and Biological Safety Manual as well as the EHS web site. All laboratory personnel are welcome to participate in University environment, health, and safety committees. Although many of these policies and procedures are directed at laboratories,
Recommended publications
  • Regulated Substance List
    INSTRUCTIONS FOR THE UNIFIED PROGRAM (UP) FORM REGULATED SUBSTANCE LIST CHEMICAL NAME CAS # TQ Listing CHEMICAL NAME CAS # TQ Listing (Lbs) Basis (Lbs) Basis Acetaldehyde 75-07-0 10,000 g Cantharidin 56-25-7 100/10,0001 * Acetone Cyanohydrin 75-86-5 1,000 Carbachol Chloride 51-83-2 500/10,0001 Acetone Thiosemicarbazide 1752-30-3 1,000/10,0001 Acetylene (Ethyne) 74-86-2 10,000 f Carbamic Acid, Methyl-,o- Acrolein (2-Propenal) 107-02-8 500 b (((2,4-Dimethyl-1,3-Dithiolan- Acrylamide 79-06-1 1,000/10,0001 2-YL) Methylene)Amino)- 26419-73-8 100/10,0001 Acrylonitrile (2- Propenenitrile) 107-13-1 10,000 b Carbofuran 1563-66-2 10/10,0001 Acrylyl Chloride Carbon Disulfide 75-15-0 10,000 b (2-Propenoyl Chloride) 814-68-6 100 b Carbon Oxysulfide Aldicarb 116-06-3 100/10,0001 (Carbon Oxide Sulfide (COS)) 463-58-1 10,000 f Aldrin 309-00-2 500/10,0001 Chlorine 7782-50-5 100 a,b Allyl Alcohol (2-Propen-1-ol) 107-18-6 1,000 b Chlorine Dioxide Allylamine (2-Propen-1-Amine) 107-11-9 500 b (Chlorine Oxide (ClO2)) 10049-04-4 1,000 c Aluminum Phosphide 20859-73-8 500 Chlorine Monoxide (Chlorine Oxide) 7791-21-1 10,000 f Aminopterin 54-62-6 500/10,0001 Chlormequat Chloride 999-81-5 100/10,0001 Amiton Oxalate 3734-97-2 100/10,0001 Chloroacetic Acid 79-11-8 100/10,0001 Ammonia, Anhydrous 2 7664-41-7 500 a,b Chloroform 67-66-3 10,000 b Ammonia, Aqueous Chloromethyl Ether (conc 20% or greater) 7664-41-7 20,000 a,b (Methane,Oxybis(chloro-) 542-88-1 100 b * Aniline 62-53-3 1,000 Chloromethyl Methyl Ether Antimycin A 1397-94-0 1,000/10,0001 (Chloromethoxymethane)
    [Show full text]
  • Laboratory Safety Manual
    LABORATORY SAFETY MANUAL Environment, Health & Safety 1120 Estes Drive Extension CB# 1650 TABLE OF CONTENTS Section or Chapter Page Introduction i Emergency Telephone Numbers ii EHS – Scope of Service iii Condensed Laboratory Safety Information for New Research Personnel v Chapter 1 – Laboratory Safety at the University of North Carolina at Chapel Hill 1-1 Chapter 2 – Laboratory Safety Plan 2-1 Chapter 3 – General Safety Principles and Practices 3-1 Chapter 4 – Proper Storage of Chemicals in Laboratories 4-1 Chapter 5 – Protective Clothing and Equipment 5-1 Chapter 6 – Safe Handling of Chemicals 6-1 Chapter 7 – Highly Toxic Chemicals and Select Carcinogens 7-1 Chapter 8 – Reproductive Health 8-1 Chapter 9 – Controlled Substances 9-1 Chapter 10 – Fire Safety 10-1 Chapter 11 – Explosive and Reactive Chemical Hazards 11-1 Chapter 12 – Management of Laboratory Wastes 12-1 Chapter 13 – Safe Handling of Peroxidizable Compounds 13-1 Chapter 14 – Safe Handling of Laboratory Animals 14-1 Chapter 15 – Safe Handling of Biological Hazards 15-1 Chapter 16 – Biological Safety Cabinets 16-1 Chapter 17 – Laboratory Hoods 17-1 Chapter 18 – Safe Use of Nanomaterials 18-1 Revisions to Laboratory Safety Manual REV-1 Laboratory Safety Manual – the University of North Carolina at Chapel Hill INTRODUCTION This manual is a safety reference document for laboratory personnel at the University of North Carolina at Chapel Hill. The University’s Department of Environment, Health & Safety prepared this manual, followed by review and approval from both the University’s Laboratory and Chemical Safety Committee (LCSC) and the University Safety and Security Committee (USSC).
    [Show full text]
  • A Simple Toxicological Analysis of Anabolic Steroid Preparations from the Black Market
    Ann Toxicol Anal. 2012; 24(2): 67-72 Available online at: c Société Française de Toxicologie Analytique 2012 www.ata-journal.org DOI: 10.1051/ata/2012011 Original article / Article original A simple toxicological analysis of anabolic steroid preparations from the black market Analyse toxicologique simple de stéroïdiens anabolisants provenant de marchés parallèles Manuela Pellegrini, Maria Concetta Rotolo, Rita Di Giovannadrea, Roberta Pacifici, Simona Pichini Department of Therapeutic Research and Medicine Evaluation, Istituto Superiore di Sanità, Via le Regina Elena 299, 00161 Rome, Italy Abstract – Objectives: A simple and rapid gas chromatography (GC) method with mass spectrometry (MS) detection was developed for the identification and quantification of anabolic steroids in pharmaceutical preparations from the black market. Material and Methods: After a liquid-liquid extraction of pharmaceutical products at acidic, neutral and basic pH with chloroform-isopropanol (9:1, v/v), the different steroids were separated by fused silica capillary column and detected by electron impact (EI)-MS in positive ionization mode. Results and Conclusion: The assay was validated in the range from 10 mg to 250 mg/g powder preparations and 0.02 mg to 200 mg/mL liquid preparations with good determination coefficients (r2 0.99) for the calibration curves. At three concentrations spanning the linear dynamic ranges of the calibration curves, mean recoveries were always higher than 90% and intra-assay and inter-assay precision and accuracy were always better than 15%. This method was successfully applied to the analysis of 15 pharmaceutical preparations sold by illegal sources. In only two cases the content was the one reported on the labels.
    [Show full text]
  • Historical Perspectives on Apple Production: Fruit Tree Pest Management, Regulation and New Insecticidal Chemistries
    Historical Perspectives on Apple Production: Fruit Tree Pest Management, Regulation and New Insecticidal Chemistries. Peter Jentsch Extension Associate Department of Entomology Cornell University's Hudson Valley Lab 3357 Rt. 9W; PO box 727 Highland, NY 12528 email: [email protected] Phone 845-691-7151 Mobile: 845-417-7465 http://www.nysaes.cornell.edu/ent/faculty/jentsch/ 2 Historical Perspectives on Fruit Production: Fruit Tree Pest Management, Regulation and New Chemistries. by Peter Jentsch I. Historical Use of Pesticides in Apple Production Overview of Apple Production and Pest Management Prior to 1940 Synthetic Pesticide Development and Use II. Influences Changing the Pest Management Profile in Apple Production Chemical Residues in Early Insect Management Historical Chemical Regulation Recent Regulation Developments Changing Pest Management Food Quality Protection Act of 1996 The Science Behind The Methodology Pesticide Revisions – Requirements For New Registrations III. Resistance of Insect Pests to Insecticides Resistance Pest Management Strategies IV. Reduced Risk Chemistries: New Modes of Action and the Insecticide Treadmill Fermentation Microbial Products Bt’s, Abamectins, Spinosads Juvenile Hormone Analogs Formamidines, Juvenile Hormone Analogs And Mimics Insect Growth Regulators Azadirachtin, Thiadiazine Neonicotinyls Major Reduced Risk Materials: Carboxamides, Carboxylic Acid Esters, Granulosis Viruses, Diphenyloxazolines, Insecticidal Soaps, Benzoyl Urea Growth Regulators, Tetronic Acids, Oxadiazenes , Particle Films, Phenoxypyrazoles, Pyridazinones, Spinosads, Tetrazines , Organotins, Quinolines. 3 I Historical Use of Pesticides in Apple Production Overview of Apple Production and Pest Management Prior to 1940 The apple has a rather ominous origin. Its inception is framed in the biblical text regarding the genesis of mankind. The backdrop appears to be the turbulent setting of what many scholars believe to be present day Iraq.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Prohibited Substances Shall Be Considered As “Specified Substances” Except Substances in Classes S1, S2, S.4.4, S.4.5, S6.A, and Prohibited Methods M1, M2 and M3
    BGBl. III - Ausgegeben am 27. Dezember 2019 - Nr. 237 1 von 8 THE 2020 PROHIBITED LIST - WORLD ANTI-DOPING CODE DATE OF ENTRY INTO FORCE: 1 JANUARY 2020 SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OF-COMPETITION) IN ACCORDANCE WITH ARTICLE 4.2.2 OF THE WORLD ANTI-DOPING CODE, ALL PROHIBITED SUBSTANCES SHALL BE CONSIDERED AS “SPECIFIED SUBSTANCES” EXCEPT SUBSTANCES IN CLASSES S1, S2, S.4.4, S.4.5, S6.A, AND PROHIBITED METHODS M1, M2 AND M3. PROHIBITED SUBSTANCES Androstenediol (androst-5-ene-3β,17β-diol); Androstenedione (androst-4-ene-3,17-dione); S0. NON-APPROVED SUBSTANCES Bolasterone; Boldenone; Any pharmacological substance which is not Boldione (androsta-1,4-diene-3,17-dione); addressed by any of the subsequent sections of Calusterone; the List and with no current approval by any Clostebol; governmental regulatory health authority for Danazol ([1,2]oxazolo[4',5':2,3]pregna-4-en- human therapeutic use (e.g. drugs under pre- 20-yn-17α-ol); clinical or clinical development or discontinued, Dehydrochlormethyltestosterone (4-chloro- designer drugs, substances approved only for 17β-hydroxy-17α-methylandrosta-1,4-dien-3- veterinary use) is prohibited at all times. one); Desoxymethyltestosterone (17α-methyl-5α- S1. ANABOLIC AGENTS androst-2-en-17β-ol); Drostanolone; Anabolic agents are prohibited. Epiandrosterone (3β-hydroxy-5α-androstan- …………………………………………………… 17-one); 1. ANABOLIC ANDROGENIC STEROIDS Epi-dihydrotestosterone (17β-hydroxy-5β- (AAS) androstan-3one); Epitestosterone; when administered exogenously, including but
    [Show full text]
  • Calarp) Program
    California Accidental Release Prevention (CalARP) Program Administering Agency Guidance January 31, 2005 Preface This document provides general guidance to help Administering Agencies (AAs) implement and enforce the California Accidental Release Prevention (CalARP) Program. The intent is to identify the elements of the Program applicable to each regulated business, and assist AAs with oversight of the CalARP Program statutes and regulations. This document is not a substitute for the CalARP Program regulations; it does not impose legally binding requirements. About This Document This document follows the format of the California Code of Regulations, Title 19, Division 2, Chapter 4.5: California Accidental Release Prevention (CalARP) Program. The regulatory sections are presented in parentheses for ease of reference. Acknowledgements The California Emergency Management Agency (Cal EMA) would like to thank the following people for their valuable assistance in the preparation of this document: Howard Wines, Hazardous Materials Specialist, City of Bakersfield Fire Department Robert Distaso P.E., Fire Safety Engineer, Orange County Fire Authority Randall L. Sawyer, Supervisor, Accidental Release Prevention Programs, Contra Costa County Health Services Department Beronia Beniamine, Senior Hazardous Materials Specialist, Stanislaus County Environmental Resources Department Angie Proboszcz, Risk Management Program Coordinator, USEPA Region 9 Jon Christenson, Senior Environmental Health Specialist, Merced County Department of Public Health Teresa
    [Show full text]
  • MICROCOMP Output File
    108TH CONGRESS 2D SESSION S. 2195 AN ACT To amend the Controlled Substances Act to clarify the defini- tion of anabolic steroids and to provide for research and education activities relating to steroids and steroid precursors. 1 Be it enacted by the Senate and House of Representa- 2 tives of the United States of America in Congress assembled, 3 SECTION 1. SHORT TITLE. 4 This Act may be cited as the ‘‘Anabolic Steroid Con- 5 trol Act of 2004’’. 2 1 SEC. 2. AMENDMENTS TO THE CONTROLLED SUBSTANCES 2 ACT. 3 (a) DEFINITIONS.—Section 102 of the Controlled 4 Substances Act (21 U.S.C. 802) is amended— 5 (1) in paragraph (41)— 6 (A) by realigning the margin so as to align 7 with paragraph (40); and 8 (B) by striking subparagraph (A) and in- 9 serting the following: 10 ‘‘(A) The term ‘anabolic steroid’ means any drug or 11 hormonal substance, chemically and pharmacologically re- 12 lated to testosterone (other than estrogens, progestins, 13 corticosteroids, and dehydroepiandrosterone), and 14 includes— 15 ‘‘(i) androstanediol— 16 ‘‘(I) 3β,17β-dihydroxy-5α-androstane; and 17 ‘‘(II) 3α,17β-dihydroxy-5α-androstane; 18 ‘‘(ii) androstanedione (5α-androstan-3,17- 19 dione); 20 ‘‘(iii) androstenediol— 21 ‘‘(I) 1-androstenediol (3β,17β-dihydroxy- 22 5α-androst-1-ene); 23 ‘‘(II) 1-androstenediol (3α,17β-dihydroxy- 24 5α-androst-1-ene); 25 ‘‘(III) 4-androstenediol (3β,17β-dihydroxy- 26 androst-4-ene); and †S 2195 ES 3 1 ‘‘(IV) 5-androstenediol (3β,17β-dihydroxy- 2 androst-5-ene); 3 ‘‘(iv) androstenedione— 4 ‘‘(I) 1-androstenedione ([5α]-androst-1-en- 5 3,17-dione);
    [Show full text]
  • Effects of Androgenic-Anabolic Steroids on Apolipoproteins and Lipoprotein (A) F Hartgens, G Rietjens, H a Keizer, H Kuipers, B H R Wolffenbuttel
    253 Br J Sports Med: first published as 10.1136/bjsm.2003.000199 on 21 May 2004. Downloaded from ORIGINAL ARTICLE Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a) F Hartgens, G Rietjens, H A Keizer, H Kuipers, B H R Wolffenbuttel ............................................................................................................................... Br J Sports Med 2004;38:253–259. doi: 10.1136/bjsm.2003.000199 Objectives: To investigate the effects of two different regimens of androgenic-anabolic steroid (AAS) administration on serum lipid and lipoproteins, and recovery of these variables after drug cessation, as indicators of the risk for cardiovascular disease in healthy male strength athletes. Methods: In a non-blinded study (study 1) serum lipoproteins and lipids were assessed in 19 subjects who self administered AASs for eight or 14 weeks, and in 16 non-using volunteers. In a randomised double blind, placebo controlled design, the effects of intramuscular administration of nandrolone decanoate (200 mg/week) for eight weeks on the same variables in 16 bodybuilders were studied (study 2). Fasting serum concentrations of total cholesterol, triglycerides, HDL-cholesterol (HDL-C), HDL2-cholesterol (HDL2- C), HDL3-cholesterol (HDL3-C), apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), and lipoprotein (a) (Lp(a)) were determined. Results: In study 1 AAS administration led to decreases in serum concentrations of HDL-C (from 1.08 (0.30) to 0.43 (0.22) mmol/l), HDL2-C (from 0.21 (0.18) to 0.05 (0.03) mmol/l), HDL3-C (from 0.87 (0.24) to 0.40 (0.20) mmol/l, and Apo-A1 (from 1.41 (0.27) to 0.71 (0.34) g/l), whereas Apo-B increased from 0.96 (0.13) to 1.32 (0.28) g/l.
    [Show full text]
  • UFC PROHIBITED LIST Effective June 1, 2021 the UFC PROHIBITED LIST
    UFC PROHIBITED LIST Effective June 1, 2021 THE UFC PROHIBITED LIST UFC PROHIBITED LIST Effective June 1, 2021 PART 1. Except as provided otherwise in PART 2 below, the UFC Prohibited List shall incorporate the most current Prohibited List published by WADA, as well as any WADA Technical Documents establishing decision limits or reporting levels, and, unless otherwise modified by the UFC Prohibited List or the UFC Anti-Doping Policy, Prohibited Substances, Prohibited Methods, Specified or Non-Specified Substances and Specified or Non-Specified Methods shall be as identified as such on the WADA Prohibited List or WADA Technical Documents. PART 2. Notwithstanding the WADA Prohibited List and any otherwise applicable WADA Technical Documents, the following modifications shall be in full force and effect: 1. Decision Concentration Levels. Adverse Analytical Findings reported at a concentration below the following Decision Concentration Levels shall be managed by USADA as Atypical Findings. • Cannabinoids: natural or synthetic delta-9-tetrahydrocannabinol (THC) or Cannabimimetics (e.g., “Spice,” JWH-018, JWH-073, HU-210): any level • Clomiphene: 0.1 ng/mL1 • Dehydrochloromethyltestosterone (DHCMT) long-term metabolite (M3): 0.1 ng/mL • Selective Androgen Receptor Modulators (SARMs): 0.1 ng/mL2 • GW-1516 (GW-501516) metabolites: 0.1 ng/mL • Epitrenbolone (Trenbolone metabolite): 0.2 ng/mL 2. SARMs/GW-1516: Adverse Analytical Findings reported at a concentration at or above the applicable Decision Concentration Level but under 1 ng/mL shall be managed by USADA as Specified Substances. 3. Higenamine: Higenamine shall be a Prohibited Substance under the UFC Anti-Doping Policy only In-Competition (and not Out-of- Competition).
    [Show full text]
  • Dichloroethylene
    Development Support Document Final, October 15, 2007 Accessible 2013 1,1-Dichloroethylene CAS Registry Number: 75-35-4 Prepared by Shannon Ethridge, M.S. Toxicology Section Chief Engineer’s Office ___________________________________________________________ TEXAS COMMISSION ON ENVIRONMENTAL QUALITY 1,1 Dichloroethylene Page 2 TABLE OF CONTENTS CHAPTER 1 SUMMARY TABLES ........................................................................................... 4 CHAPTER 2 MAJOR USES OR SOURCES ............................................................................ 6 CHAPTER 3 ACUTE EVALUATION ....................................................................................... 6 3.1 HEALTH-BASED ACUTE REV AND ESL ................................................................................. 6 3.1.1 Physical/Chemical Properties and Key Studies ............................................................. 6 3.1.2 Mode-of-Action (MOA) Analysis ................................................................................. 10 3.1.3 Dose Metric .................................................................................................................. 10 3.1.4 Point of Departure (POD) for the Key Study............................................................... 10 3.1.5 Dosimetric Adjustments ............................................................................................... 11 3.1.6 Critical Effect and Adjustment of PODHEC .................................................................. 11 3.1.7 Health-Based
    [Show full text]
  • Us Anti-Doping Agency
    2019U.S. ANTI-DOPING AGENCY WALLET CARDEXAMPLES OF PROHIBITED AND PERMITTED SUBSTANCES AND METHODS Effective Jan. 1 – Dec. 31, 2019 CATEGORIES OF SUBSTANCES PROHIBITED AT ALL TIMES (IN AND OUT-OF-COMPETITION) • Non-Approved Substances: investigational drugs and pharmaceuticals with no approval by a governmental regulatory health authority for human therapeutic use. • Anabolic Agents: androstenediol, androstenedione, bolasterone, boldenone, clenbuterol, danazol, desoxymethyltestosterone (madol), dehydrochlormethyltestosterone (DHCMT), Prasterone (dehydroepiandrosterone, DHEA , Intrarosa) and its prohormones, drostanolone, epitestosterone, methasterone, methyl-1-testosterone, methyltestosterone (Covaryx, EEMT, Est Estrogens-methyltest DS, Methitest), nandrolone, oxandrolone, prostanozol, Selective Androgen Receptor Modulators (enobosarm, (ostarine, MK-2866), andarine, LGD-4033, RAD-140). stanozolol, testosterone and its metabolites or isomers (Androgel), THG, tibolone, trenbolone, zeranol, zilpaterol, and similar substances. • Beta-2 Agonists: All selective and non-selective beta-2 agonists, including all optical isomers, are prohibited. Most inhaled beta-2 agonists are prohibited, including arformoterol (Brovana), fenoterol, higenamine (norcoclaurine, Tinospora crispa), indacaterol (Arcapta), levalbuterol (Xopenex), metaproternol (Alupent), orciprenaline, olodaterol (Striverdi), pirbuterol (Maxair), terbutaline (Brethaire), vilanterol (Breo). The only exceptions are albuterol, formoterol, and salmeterol by a metered-dose inhaler when used
    [Show full text]